Pharmacodynamics of taniborbactam in combination with cefepime studied in an in vitro model of infection
Author:
Funder
North Bristol NHS Trust
ARS Pharmaceuticals
Publisher
Elsevier BV
Reference20 articles.
1. VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa;Hamrick;Antimicrob Agents Chemother,2020
2. CERTAIN-1: a phase 3 study of cefepime-taniborbactam efficacy and safety in the treatment of complicated urinary tract infections (cUTI), including acute pyelonephritis (AP);McGovern;Open Forum Infectious Diseases,2022
3. Jones RN pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime;Ambrose;J Antimicrob Chemother,2002
4. Impact of extended spectrum beta-lactamase (ESBL) production on the activity of cefepime in a murine thigh infection model Abstracts of the 41st ICAAC, Chicago;Andes,2001
5. Nicolau DP Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula;Maglio;Antimicrob Agents Chemother,2004
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3